Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lurasidone Hydrochloride 40 mg vs Latuda under fed conditions in healthy Thai volunteers
TCTR20230214005Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lurasidone (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
lurasidone
Beyond the preview
Go deeper on TCTR20230214005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230214005.